PSMA and FDG PET/CT Findings in Patient With Dedifferentiated Liposarcoma and Prostate Cancer Metastases

Xuhe Liao,Hongwei Sun,Xueqi Chen,Yan Fan,Jianhua Zhang
DOI: https://doi.org/10.1097/rlu.0000000000005252
IF: 10.6
2024-06-04
Clinical Nuclear Medicine
Abstract:Dedifferentiated liposarcoma is an extremely rare and highly malignant tumor. We demonstrated a case of a 75-year-old man with significantly PSMA-avid and mildly FDG uptake–dedifferentiated liposarcoma in the retroperitoneal area. The double-tracer (PSMA and FDG) PET scans could further contribute to differential diagnosis and the following treatment strategy for patients who were suspected with prostate cancer metastases and other malignant tumors simultaneously.
radiology, nuclear medicine & medical imaging
What problem does this paper attempt to address?